HLA class I antigens are possible prognostic factors in hepatocellular carcinoma

International Journal of Oncology

Volumn 8, Issue 6, 1996, Pages 1243-1247

  Nishibe, Manabu ^a   Ube, Y ^a   Kobayashi, M ^a   Kuramitsu, Y ^a   Hosokawa, M ^a   Uchino, J ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

disease free survival time; flow cytometry; hepatocellular carcinoma; HLA class I antigens; intrahepatic metastases; tumor malignancy

Indexed keywords

HLA ANTIGEN CLASS 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029936297     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.6.1243     Document Type: Article

References (2)

1. Farmer DG, Rosove MH, Shaked A and Busuttil RW: Current treatment modalities for hepatocellular carcinoma. Ann Surg 219: 236-247, 1994.
2. Ogasawara K, Une Y, Nakajima Y and Uchino J: The significance of measuring liver volume using computed tomographic images before and after hepatectomy. Surg Today 25: 43-48, 1995.